Najarian J S, So S K, Simmons R L, Fryd D S, Nevins T E, Ascher N L, Sutherland D E, Payne W D, Chavers B M, Mauer S M
Ann Surg. 1986 Sep;204(3):246-58. doi: 10.1097/00000658-198609000-00004.
Of 304 children who received primary renal transplants at the University of Minnesota between January 1, 1968, and December 31, 1985, 48 (16%) were under the age of 24 months, 60 (20%) were 2-5 years old, and 196 (64%) were 6-17 years old at transplantation. Currently, 254 (84%) are alive at 2 months to 18 years following their first transplants, 77% with functioning grafts (188 first, 45 retransplants) and 7% on dialysis. Overall, patient and graft survival were not significantly different from the primary graft outcome of nondiabetic adults. The actuarial primary graft function rates at 1, 5, and 10 years were 100, 100, and 90% in 16 HLA-identical sibling kidneys; 84, 64, and 52% in 210 mismatched related kidneys; and 72, 54, and 47% in 78 cadaver kidneys (p less than 0.002). The 1-year patient survival and primary graft function rates in 44 mismatched related recipients under the age of 24 months were 92 and 88%. The use of deliberate, pretransplant random blood transfusion since 1979 has been associated with a decreased rejection rate. Primary graft function of mismatched related kidneys in children receiving standard immunosuppression has significantly improved from 78% at 1 year in the pretransfusion era to 91% (p less than 0.01) in the transfusion era. The overall primary cadaver graft function rate, however, did not improve in the transfusion era. Whether cyclosporine use will improve the cadaver renal allograft function in very young recipients remains to be established. However, with the use of related donors, even very young children can be transplanted safely and with excellent results.
1968年1月1日至1985年12月31日期间,在明尼苏达大学接受初次肾移植的304名儿童中,48名(16%)在移植时年龄小于24个月,60名(20%)为2至5岁,196名(64%)为6至17岁。目前,254名(84%)在首次移植后2个月至18年存活,77%的移植肾有功能(188例初次移植,45例再次移植),7%接受透析治疗。总体而言,患者和移植肾存活率与非糖尿病成年人的初次移植结果无显著差异。16例HLA配型相同的同胞供肾在1年、5年和10年的精算初次移植肾功能率分别为100%、100%和90%;210例配型不相合的亲属供肾分别为84%、64%和52%;78例尸体供肾分别为72%、54%和47%(p<0.002)。44例年龄小于24个月的配型不相合亲属受者的1年患者存活率和初次移植肾功能率分别为92%和88%。自1979年以来,采用计划性的移植前随机输血与排斥率降低有关。接受标准免疫抑制的儿童中,配型不相合亲属供肾的初次移植肾功能已从输血前时代的1年时的78%显著提高到输血时代的91%(p<0.01)。然而,输血时代尸体供肾的总体初次移植肾功能率并未改善。环孢素的使用是否会改善极年幼受者的尸体肾移植功能仍有待确定。然而,使用亲属供者,即使是非常年幼的儿童也能安全地进行移植并取得良好效果。